#ResearchNeverStops

EVT Execute

Our services

EVT Innovate

Our R&D initiatives

Action Plan

The data-driven R&D Autobahn to Cures

Science Pool

Evotec's new scientific content hub

Career

What you can contribute

Invest

How you can participate

Highlights

DDup 11

AI-driven antibody discovery at Evotec

DDup 10

Evotec’s transforming transcriptomics toxicology platform

News View all news

Evotec publishes DDup 11 – AI-driven antibody discovery at Evotec

Hamburg, Germany, 15 Sep 2021

The 11th edition is dedicated to our exciting new capabilities in the biologics lane of Evotec’s “Multi-modality...

Read more

Evotec partner Bayer: Phase IIb trial shows eliapixant significantly decreases cough frequency in patients with refractory chronic cough

Berlin, Germany, 06 Sep 2021

Evotec partner Bayer today reported more detailed results from PAGANINI, the Phase IIb dose-finding study evaluating the efficacy and...

Read more

Investor Relations Events View all events

16 November2021

Jefferies Global Healthcare Conference in London Organisers: Jefferies

11 November2021

Quarterly Statement 9M 2021 and webcast

Company Presentation

Download our Company Presentation

September 2021

Download

TOP